The management of anemia in cardiorenal syndrome requires a complex approach that takes into account the following aspects: the classification of kidney and heart disease, the iron status, Hb levels, left ventricular ejection fraction, eGFR, and natriuretic peptide concentration [10]. This evidence concerns the gene GSTM1 and anemia (phenotype).